T. Rowe Price Associates’s iShares Biotechnology ETF IBB Stock Holding History

T. Rowe Price Associates’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$338K	Hold	2,000	–	–	﹤0.01%	2630
2025 Q4	$338K	Hold	2,000	–	–	﹤0.01%	2588
2025 Q3	$289K	Sell	2,000 -1,614	-45%	-$220K	﹤0.01%	2620
2025 Q2	$458K	Hold	3,614	–	–	﹤0.01%	2347
2025 Q1	$463K	Hold	3,614	–	–	﹤0.01%	2277
2024 Q4	$478K	Hold	3,614	–	–	﹤0.01%	2305
2024 Q3	$527K	Hold	3,614	–	–	﹤0.01%	2225
2024 Q2	$497K	Hold	3,614	–	–	﹤0.01%	2189
2024 Q1	$496K	Hold	3,614	–	–	﹤0.01%	2214
2023 Q4	$491K	Hold	3,614	–	–	﹤0.01%	2180
2023 Q3	$442K	Hold	3,614	–	–	﹤0.01%	2169
2023 Q2	$459K	Hold	3,614	–	–	﹤0.01%	2177
2023 Q1	$467K	Hold	3,614	–	–	﹤0.01%	2140
2022 Q4	$474K	Hold	3,614	–	–	﹤0.01%	2152
2022 Q3	$423K	Hold	3,614	–	–	﹤0.01%	2212
2022 Q2	$425K	Hold	3,614	–	–	﹤0.01%	2285
2022 Q1	$471K	Hold	3,614	–	–	﹤0.01%	2368
2021 Q4	$552K	Hold	3,614	–	–	﹤0.01%	2340
2021 Q3	$584K	Hold	3,614	–	–	﹤0.01%	2306
2021 Q2	$591K	Sell	3,614 -89	-2%	-$13.7K	﹤0.01%	2311
2021 Q1	$558K	Buy	3,703 +89	+2%	+$14.1K	﹤0.01%	2318
2020 Q4	$547K	Buy	+3,614	New	+$516K	﹤0.01%	2206

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

T. Rowe Price Associates's IBB Position: Q1 2026 in Review

T. Rowe Price Associates held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 2,000 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #2630.

T. Rowe Price Associates first reported a position in IBB in Q4 2020 and has held it in 22 quarters since. The position peaked at $591K in Q2 2021. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

T. Rowe Price Associates held 2,000 shares of iShares Biotechnology ETF worth $338K as of Q1 2026.
T. Rowe Price Associates left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2630 holding.
T. Rowe Price Associates first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 22 quarters since.
T. Rowe Price Associates's iShares Biotechnology ETF position peaked at $591K in Q2 2021.
919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.